Product Information
CAPECITABINE 150 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.3615 per EA under NDC 68001048706. Its NADAC has been published 110 times since May 22, 2024.
Strength
150 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001048706
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CAPECITABINEApproval Type
Generic (ANDA)
FDA Application
ANDA202593On Market Since
2/22/2021
Pharmacological Classes
Price Statistics
The NADAC for CAPECITABINE 150 MG TABLET has been published 110 times since May 22, 2024, and over the history we have for it it has declined 33.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3615 per EA |
|---|---|
| All-time high | $0.5392 (Jun 12, 2024) |
| All-time low | $0.2292 (Mar 19, 2025) |
| 52-week high | $0.4038 |
| 52-week low | $0.3615 |
| Median price | $0.3955 |
| Average price | $0.3642 |
| Largest weekly change | -37.1% (Nov 20, 2024) |
| Weeks tracked | 110 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CAPECITABINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPECITABINE 150 MG TABLET, manufactured by BluePoint Laboratories, is $0.3615 per EA (NDC 68001048706), effective Jun 24, 2026.
How has the price of CAPECITABINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPECITABINE 150 MG TABLET has declined 33.0%. It has been tracked across 110 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for CAPECITABINE 150 MG TABLET?
Since May 22, 2024, the NADAC for CAPECITABINE 150 MG TABLET has ranged from a low of $0.2292 (Mar 19, 2025) to a high of $0.5392 (Jun 12, 2024), with a median of $0.3955 per EA.
Are there cheaper alternatives to CAPECITABINE 150 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CAPECITABINE 150 MG TABLET, but none are currently priced below it.
Who manufactures CAPECITABINE 150 MG TABLET?
CAPECITABINE 150 MG TABLET (NDC 68001048706) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification